It's X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men

    September 2020 in “ Journal of the Endocrine Society ”
    Philip Angelides, Ishita Jindal, Lefkothea Karaviti, Mitchell E. Geffner
    Image of study
    TLDR Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.
    The document from September 2020 examined why men have higher morbidity and mortality rates from COVID-19 than women. It proposed that the X chromosome, with its immune-related genes, gives women an immunological edge due to their two copies, while men only have one. Estrogen was suggested to offer protection against severe SARS-CoV infections in females, whereas androgens might dampen the immune response in males, leading to poorer outcomes. The interaction between the androgen receptor on the X chromosome and the TMPRSS2 gene, crucial for the virus's entry into cells, was identified as a significant factor in the sex differences in disease severity. Additionally, the lower expression of the androgen receptor in prepubertal children was associated with a decreased risk of SARS-CoV-2 infection. The reasons for worse outcomes in males were considered to be complex, involving a combination of genetic, hormonal, and sex-specific vulnerabilities.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Adrogens and Covid-19

      in Treatment  7 upvotes 4 years ago
      The possible increased risk of severe Covid-19 cases in men due to higher androgen levels, and how taking medications such as finasteride, dutasteride, spironolactone, enzalutamide, or canabidiol might help mitigate the severity of the disease.

      community Trestolone (MENT) as a nuclear treatment

      in Treatment  99 upvotes 2 years ago
      Experimenting with trestolone as a treatment for hair loss in an attempt to avoid DHT-related treatments such as finasteride and dutasteride, and discussing the potential effects of its receptor selectivity on the androgen receptors in the scalp.

      community How true is the statement: dead follicles don't grow back?

      in Research/Science  107 upvotes 1 month ago
      Hair follicles usually go dormant rather than die, and treatments like finasteride, minoxidil, and hormone therapy can sometimes reactivate them, though results vary. Complete regrowth is rare, especially in long-term bald areas, but some individuals see significant improvement with these treatments.

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 6 months ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

    Similar Research

    5 / 1000+ results